As of 4:00pm ET
| -0.02 / -1.67%|
The 3 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 1.60. The median estimate represents a +577.97% increase from the last price of 1.18.
The current consensus among 3 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.